University of 91勛圖 engineers have joined forces with microbiologists at Trinity College in Dublin, Ireland, to further investigate a promising strategy for managing cystic fibrosis lung infections.
Cystic fibrosis, an inherited disease that causes patients��� airways to fill with a thick and sticky mucus, affects many people around the world.
Ireland has the highest incidence per capita ��� triple that of the United States ��� and is home to a significant number of researchers who focus on this disease.
Treating cystic fibrosis lung infections is particularly challenging because they consist of biofilms ��� aggregates of bacteria encased in a gel-like matrix that are highly resistant to antibiotics.
捩娶梗措勳棗喝莽梭聆,泭, environmental engineer and biofilms expert, and��, a civil engineer,��along with doctoral student��Yanina Nahum, demonstrated how����greatly increases the effectiveness of the antibiotics.
Now the researchers are partnering with��, assistant professor of microbiology at Trinity College, to understand exactly how low-frequency ultrasound enhances antibiotic activity. Martins��� lab researches bacteria���s cellular and molecular mechanisms of defense against antimicrobials.��
Nahum spent the summer in Ireland working in Martins��� lab, where she learned new methods for analyzing bacterial resistance to antibiotics, especially via efflux pumps.
���We know that low-frequency ultrasound is impairing the bacteria���s ability to defend themselves,��� said Nahum, ���and now we have the techniques to better understand how they are doing that.���
In addition to antibiotics, treatments for cystic fibrosis include the use of vibrating vests to loosen mucus from the lungs.
The researchers envision a possible new treatment that would incorporate low-frequency ultrasound into the vibrating vest. The ultrasound could then disable the biofilms��� defense mechanisms and increase the effectiveness of antibiotics. This synergistic effect is particularly important as a way to deal with advanced stages of the disease, when multidrug-resistant biofilms tend to develop.
Low-frequency ultrasound��in combination with other types of antimicrobials may have applications beyond this project, Nerenberg said.
���Biofilms grow on devices in hospitals, such as catheters, joint prosthetics and pacemakers,��� he said. ���They���re a problem in pipes and water systems where pathogens like��Legionella��(the bacteria that cause Legionnaires��� disease) can grow.��
���By looking at the fundamentals of biofilms ��� at the cellular level��� we can determine where this new approach can be used most effectively.�����